Update on Immunization Programme and Pandemic Preparedness

1. At a Glance

• Ministry of Health and Family Welfare (MoHFW) statement (21 July 2026) consolidating progress under the Universal Immunization Programme (UIP), the new nationwide HPV vaccination campaign, and India's pandemic preparedness architecture [1].
• Relevant for Prelims (schemes, numbers, launch dates) and Mains GS-II (health policy, social justice, welfare schemes) [1].
• Ties together three threads UPSC tests separately: routine immunization coverage, cervical-cancer prevention via HPV vaccine, and post-COVID pandemic-preparedness infrastructure [1].

2. Why in the News

• MoHFW Minister of State Smt. Anupriya Patel gave a written reply in Rajya Sabha (21 July 2026) detailing UIP coverage trends, the HPV campaign, ICMR's diagnostic lab network, and the new Ayushman Arogya Mandir training module [1].
• Nationwide HPV vaccination campaign was launched on 28 February 2026 by PM Narendra Modi from Ajmer, Rajasthan [2].
• Integrated Training Module for Primary Healthcare Teams at Ayushman Arogya Mandir launched in April 2026 [1].

3. Background & Evolution

• UIP originated as the Expanded Programme on Immunization (1978), renamed Universal Immunization Programme in 1985; one of the largest public health programmes globally by volume of beneficiaries.
• National Health Policy 2017 set the goal of achieving/maintaining Full Immunization Coverage (FIC) above 90% [1].
• NTAGI (National Technical Advisory Group on Immunization) recommended HPV vaccine introduction into UIP with a one-time catch-up for 9–14 year-old girls, followed by routine introduction at age 9 [2].
• With the February 2026 launch, India joined 160+ countries that have introduced HPV vaccination into their national immunization schedules [2].
• Pandemic-preparedness build-out is post-COVID-19: PM-ABHIM (2021) for infrastructure, IDSP (Integrated Disease Surveillance Programme, launched 2004) strengthened for decentralized surveillance [1].
• WHO-India collaboration on the PRET (Preparedness and Resilience for Emerging Threats) initiative operationalized 8–9 December 2023, aiming for operational PRET-aligned national plans by 2031 under the WHO South-East Asia Regional Roadmap 2023–2027 [3].

4. Core Static Facts

5. Multi-Dimensional Analysis

Social

• HPV vaccination targets adolescent girls specifically — a gender-and-health-equity intervention against cervical cancer, India's second most common cancer among women [2].
• School-based delivery mechanism improves reach into rural/low-literacy households where awareness of cervical cancer prevention is weak [2].

Administrative

• Delivery spans Centre (NTAGI recommendation, MoHFW funding), States/UTs (implementation across all 36), and grassroots workers (ASHAs, ANMs, CHOs) — a federal implementation test case [1][2].
• Coordination challenge: reaching out-of-school girls via mobile/community outreach teams, a known gap area in adolescent health schemes [2].

Scientific/Technological

• ICMR's 160+ VRDL network provides decentralized genomic/pathogen diagnostic capacity — critical lesson learnt from COVID-19 testing bottlenecks [1].
• Integrated digital platforms (IHIP, HMIS, AAM Portal) reflect a push toward real-time, data-driven disease surveillance [1].

Governance/Ethical

• Sustained >90% FIC for four years is presented as an achievement, but bulletin-style reporting (written Parliament reply) invites scrutiny on state-wise disaggregation, urban-rural gaps, and dropout rates, which are not detailed in the release [1].
• Free-of-cost delivery addresses equity but raises questions on consent/parental awareness for a vaccine targeting minors [2].

Geopolitical/Strategic

• India's HPV rollout aligns it with WHO's global cervical cancer elimination push and the 160+ nations already vaccinating [2].
• PRET framework reflects India's integration into WHO's global health-security architecture ahead of future pandemics [3].

6. Recent Developments (last 12–18 months)

• 8–9 December 2023: PRET initiative operationalized jointly by MoHFW and WHO Country Office India [3].
• 27 January 2026: "Influenza Chintan Shivir 2025" held for interministerial/intersectoral convergence on influenza preparedness [3].
• 28 February 2026: Nationwide HPV vaccination campaign launched by PM Modi at Ajmer, Rajasthan [2].
• February–March 2026: Nationwide roll-out of HPV drive across all States/UTs with radio jingles, posters, digital/social media promotion [1].
• April 2026: Integrated Training Module for Primary Healthcare Team at Ayushman Arogya Mandir launched [1].
• 21 July 2026: MoHFW tables consolidated update in Rajya Sabha on UIP coverage, HPV campaign, ICMR labs, and AAM training [1].

7. Prelims Hooks

• National Full Immunization Coverage maintained above 90% for the last four years as per National Health Policy 2017 goals [1].
• HPV vaccination campaign launched on 28 February 2026 from Ajmer, Rajasthan, by PM Narendra Modi [2].
• Target beneficiaries of the HPV campaign: approximately 1.2 crore girls aged 14, across all 36 States and UTs [1].
• HPV vaccine introduced into UIP on recommendation of NTAGI (National Technical Advisory Group on Immunization) [2].
• HPV vaccination follows a grade-based school delivery model (classes 5th–10th) [2].
• With this launch, India joined 160+ countries with HPV vaccine in national immunization schedules [2].
• ICMR has established 160+ Virus Research and Diagnostic Laboratories (VRDLs) for pathogen diagnosis [1].
• Integrated Training Module for Primary Healthcare Team at Ayushman Arogya Mandir launched in April 2026 [1].
• AAM training module covers Medical Officers, Staff Nurses, Community Health Officers, ANMs, and ASHAs [1].
• PM-ABHIM is the scheme strengthening primary and secondary healthcare infrastructure for pandemic preparedness [1].
• IDSP (Integrated Disease Surveillance Programme) provides decentralized surveillance via Rapid Response Teams [1].
• Digital surveillance/health platforms cited: IHIP, IDSP, HMIS, AAM Portal, NP-NCD Portal [1].
• WHO's PRET (Preparedness and Resilience for Emerging Threats) initiative was operationalized with India on 8–9 December 2023 [3].
• WHO South-East Asia Regional Roadmap (2023–2027) targets operational PRET-aligned national plans by 2031 [3].
• Nodal ministry for all above initiatives: Ministry of Health and Family Welfare (not NITI Aayog or ICMR alone) [1].

8. Mains Relevance

• GS-II: Government policies and interventions for development in health sector; Welfare schemes for vulnerable sections; Issues relating to development and management of Social Sector/Services – Health.
• GS-III: Science and Technology developments (diagnostic/surveillance infrastructure); disaster/pandemic management.
• Possible question stems: 1. "Discuss the significance of the Universal Immunization Programme in India's public health architecture. What administrative challenges hinder achieving full immunization coverage?" (GS-II) 2. "Examine the rationale and implementation strategy of India's nationwide HPV vaccination campaign. How does it address gender-specific health vulnerabilities?" (GS-II) 3. "In light of lessons from COVID-19, evaluate India's institutional preparedness for future pandemics, with reference to ICMR's laboratory network and disease surveillance platforms." (GS-III)

9. Related Topics to Study Next

• Mission Indradhanush / Intensified Mission Indradhanush — the intensified drive that underpins UIP's coverage gains.
• Ayushman Bharat – PM-ABHIM — infrastructure scheme repeatedly cited alongside pandemic preparedness.
• Ayushman Arogya Mandir (formerly Health & Wellness Centres) — primary healthcare delivery backbone now hosting the new training module.
• National Health Policy 2017 — the policy target (90% FIC) being cited.
• IHR 2005 (International Health Regulations) — global legal framework underpinning India's pandemic-preparedness commitments.
• National Cancer Control Programme / cervical cancer elimination strategy — clinical rationale for HPV vaccination.
• ICMR and its institutes (NIV Pune, etc.) — apex body running the VRDL network.
• One Health approach / Zoonotic disease surveillance — related pandemic-preparedness dimension often clubbed together.

10. Common Errors / Trap Areas

• Confusing UIP (routine vaccination since 1985) with Mission Indradhanush (2014, catch-up drive for under/unvaccinated children) — they are related but distinct schemes.
• Assuming HPV vaccine target age is "9 years" — the routine introduction age is 9; the 2026 catch-up campaign specifically targets 14-year-olds.
• Attributing ICMR's VRDL network to MoHFW directly — ICMR is an autonomous body under MoHFW's Department of Health Research (DHR), not MoHFW's direct line department.
• Mixing up Ayushman Arogya Mandir (rebranded Health & Wellness Centres under Ayushman Bharat) with Ayushman Bharat-PMJAY (the insurance scheme) — different components of the same umbrella mission.
• Treating PRET as an Indian scheme — it is a WHO global initiative India has adopted, not a domestically originated programme.